CQC annual report promotes pharmacy role to help health and social care pressures

CQC annual report promotes pharmacy role to help health and social care pressures

October 13 2017 PSNC has called on the NHS to make greater use of community pharmacy services, in...

RPS and APTUK issue statement committing to partnership working

RPS and APTUK issue statement committing to partnership working

October 12 2017 A five year road map setting out how pharmacists and pharmacy technicians can...

PDA calls for community pharmacy to be included in Health Service Safety Investigations Bill

PDA calls for community pharmacy to be included in Health Service Safety Investigations Bill

September 26 2017 Community pharmacy should be included within the remit of a new body being set...

Pharmacy organisations speak out on pharmacy technicians supervising medicines supply

Pharmacy organisations speak out on pharmacy technicians supervising medicines supply

September 26 2017 Pharmacy bodies have responded to concerns that registered pharmacy technicians...

Wales launches its own Tobacco Control Delivery Plan

Wales launches its own Tobacco Control Delivery Plan

September 25 2017 The Welsh Government has set out measures to reduce the number of smokers in...

  • CQC annual report promotes pharmacy role to help health and social care pressures

    CQC annual report promotes pharmacy role to help health and social care pressures

    Friday, 13 October 2017 09:51
  • RPS and APTUK issue statement committing to partnership working

    RPS and APTUK issue statement committing to partnership working

    Thursday, 12 October 2017 14:54
  • PDA calls for community pharmacy to be included in Health Service Safety Investigations Bill

    PDA calls for community pharmacy to be included in Health Service Safety Investigations Bill

    Tuesday, 26 September 2017 14:34
  • Pharmacy organisations speak out on pharmacy technicians supervising medicines supply

    Pharmacy organisations speak out on pharmacy technicians supervising medicines supply

    Tuesday, 26 September 2017 14:25
  • Wales launches its own Tobacco Control Delivery Plan

    Wales launches its own Tobacco Control Delivery Plan

    Monday, 25 September 2017 13:44

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

pills4June 27 2016

Guidance on naloxone supply has been updated with advice about what to consider when there is a need for use in people under 18 years.

The guidelines were introduced in October 2015 as part of a move to widen the availability of naloxone as an emergency antidote for overdoses caused by heroin and other opiates or opioids such as methadone and morphine.

They are intended for use by drug treatment services authorised to supply naloxone, including:

  • drug services commissioned from primary care providers
  • drug services commissioned from secondary care providers (including a range of specialised community and inpatient drug services)
  • commissioned services providing needle and syringe programmes (including those provided from pharmacies)
  • pharmacies providing drug treatment services.

The update says that “any drug treatment service considering providing a child or young person under 18 with training on overdose management or on the use of naloxone, or considering direct supply of naloxone, should always act in line with established clinical principles for the treatment of children and young people.

“This is the case whether the goal of such consideration is to reduce risks to a young person who is using drugs or to reduce risk for others (such as an opioid-using parent).”

It points out that there are no legal restrictions under the 2015 legislation, and that “such a decision would need very careful consideration and oversight and would need to be made on a case by case basis.

“An appropriately competent professional acting within a suitable clinical governance framework would have to consider the needs of each child or young person, taking account of potential benefits to the child of the intervention and any risks.”

Factors they would need to take into account include the child or young person’s ability to understand the issues involved and to provide suitable consent. “In the case of a child who exercises a carer role for a drug-using parent, consideration of the interests of the child can be quite complex.” There is also a need to consider issues such as those relating to child safeguarding.

Links:

Department of Health Guidance

Updated guidance

Legal & Policy News

October 17 2017 A consultation has opened on new standards for pharmacy premises in Northern Ireland. Running until November 27, it seeks views on proposed changes which will “mark a shift towards...
December 7 2015 Pharmacists in Scotland have been asked to share their views on what politicians need to be made aware of ahead of the Scottish Parliament elections in 2016. The Royal Pharmaceutical Society...